Literature DB >> 10356415

Pro and contra of specific hyposensitization.

S Karl1, J Ring.   

Abstract

Specific hyposensitization is the practice of administering gradually increasing quantities of a specifically relevant allergen to allergic patients until reaching a maintenance dose or loss of symptoms. The most important hypothesis regarding the mechanism is a switch from a Th 2- into a Th 1 reaction pattern in the T cell regulation. The efficacy of specific hyposensitization has been assessed in controlled studies. Allergen extracts are obtained by extraction of the active constituents from animal or vegetable substances with a suitable menstruum. There is a great assortment of different allergen extracts available, but only standardized extracts should be used. Specific hyposensitization is a causal treatment for patients with IgE-mediated allergies like seasonal or perennial allergic rhino-conjunctivitis, asthma or hymenoptera venom allergy. The principal and most effective route of allergen application is the subcutaneous injection. The risk of side effects, especially life threatening anaphylaxis must be considered and can be minimized by careful allergology practice. Oral/sublingual application of allergen extracts is still discussed controversially. Specific hyposensitization requires the high motivation and cooperation of an informed patient.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10356415

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  3 in total

Review 1.  Allergen-specific immunotherapy in atopic eczema.

Authors:  Ulf Darsow; Ingeborg Forer; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2011-08       Impact factor: 4.806

2.  Self-peptides prolong survival in murine autoimmunity via reduced IL-2/IL-7-mediated STAT5 signaling, CD8 coreceptor, and V alpha 2 down-regulation.

Authors:  Jan Gutermuth; Kristine E Nograles; Fumi Miyagawa; Emily Nelson; Young-Hun Cho; Stephen I Katz
Journal:  J Immunol       Date:  2009-08-12       Impact factor: 5.422

Review 3.  Clinical Relevance of Pre-Existing and Treatment-Induced Anti-Poly(Ethylene Glycol) Antibodies.

Authors:  Helena Freire Haddad; Jacqueline A Burke; Evan A Scott; Guillermo A Ameer
Journal:  Regen Eng Transl Med       Date:  2021-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.